Exploring the Potential of Psychedelics and Natural Compounds

Dick Simon, the founder of Sensorium Therapeutics, discusses his journey and motivation in the field of psychedelics. Inspired by a friend's success with psychedelics in treating mental health issues, Dick embarked on a mission to advance research and de-stigmatization. He he joins Ross O'Brien  from Bonaventure Equity to talk about  co-founding Sensorium to create novel pharmaceuticals using a comprehensive database of psychoactive plants and fungi, leveraging artificial intelligence and machine learning for drug discovery. The company aims to have a significant impact in mental health and provide alternative treatment options for those who may not benefit from traditional psychedelics therapies.

Produced by PodConx

Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

Bonaventure Equity - https://link.bve.vc/Visit-Us

Dick Simons - https://www.linkedin.com/in/dick-simon-6050ba5/

Sensorium Therapeutics - https://www.sensorium.bio/